Ten Capital Wealth Advisors’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-109
Closed -$2.56K 415
2023
Q1
$2.56K Hold
109
﹤0.01% 452
2022
Q4
$3.04K Sell
109
-15
-12% -$384 ﹤0.01% 418
2022
Q3
$3K Sell
124
-3
-2% -$91 ﹤0.01% 463
2022
Q2
$4K Hold
127
﹤0.01% 351
2022
Q1
$4K Buy
127
+4
+3% +$137 ﹤0.01% 395
2021
Q4
$4K Hold
123
﹤0.01% 390
2021
Q3
$4K Buy
123
+100
+435% +$3.2K ﹤0.01% 337
2021
Q2
$1K Buy
+23
New +$757 ﹤0.01% 453

Other funds holding OGN

Ten Capital Wealth Advisors's OGN Position: Q2 2023 in Review

Ten Capital Wealth Advisors sold out of Organon & Co (OGN) in Q2 2023, closing a stake of 109 shares — an estimated $2.56K sold.

Ten Capital Wealth Advisors first reported a position in OGN in Q2 2021 and held it in 8 quarters. The position peaked at $4K in Q2 2022. 728 funds tracked by Wall St. Rank hold OGN as of Q2 2023.

  • Ten Capital Wealth Advisors reported no remaining Organon & Co position as of Q2 2023 after selling out during the quarter.
  • Ten Capital Wealth Advisors sold 109 Organon & Co shares in Q2 2023, an estimated $2.56K.
  • Ten Capital Wealth Advisors first reported a position in Organon & Co in Q2 2021 and held it in 8 quarters.
  • Ten Capital Wealth Advisors's Organon & Co position peaked at $4K in Q2 2022.
  • 728 funds tracked by Wall St. Rank held Organon & Co as of Q2 2023.

Based on Ten Capital Wealth Advisors's 13F filing for Q2 2023, filed 31 Jul 2023.